Genome-Based Diagnostics Demonstrating Clinical Utility in Oncology: Workshop Summary (2013) / Chapter Skim
Currently Skimming:
Appendix B: Speaker Biographical Sketches
Appendix B: Speaker Biographical Sketches
Pages 81-94
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 81... ...
Bast completed a medical residency at the Peter Bent Brigham Hospital and a fellowship in medical oncology at the Dana-Farber Cancer Institute. He joined the faculty at Harvard as an assistant professor and was subsequently appointed associate professor at the Dana-Farber Cancer Institute.
|
From page 82... ...
He also is the chair of both the Eastern Cooperative Oncology Group Gastrointestinal and Data Monitoring Committees and a member of the National Cancer Institute Gastrointestinal Steering Committee. In addition, he is a past president of the Illinois Medical Oncology Society, past president of the Association of Community Cancer Centers (ACCC)
|
From page 83... ...
Dr. Benson is on the editorial board of the ASCO Connection, American Health and Drug Benefits, Personalized Medicine in Oncology, Journal of Comparative Effectiveness Research, and Gastrointestinal Cancer Research, among other publications.
|
From page 84... ...
His postgraduate education included clinical and research positions at Cornell Medical Center and New York Hospital, Memorial Sloan-Kettering Cancer Center, and the National Cancer Institute.
|
From page 85... ...
Dr. Freedman also directed multidisciplinary molecular, clinical, and translational epidemiology studies within the HMO Cancer Research Network; Department of Veterans Affairs medical system; NCI's Surveillance, Epidemiology, and End Results Program; and the National Institutes of Health (NIH)
|
From page 86... ...
, is professor of medicine and director of comparative effectiveness and outcomes research– oncology at Duke University and the Duke Cancer Institute.
|
From page 87... ...
His research interests include personalized cancer supportive care, comparative effectiveness studies of targeted therapies and biomarkers, mathematical and statistical prognostic and predictive models, advanced methods of evidence synthesis in support of clinical practice guidelines and population studies of patterns of cancer treatment, and the impact of health disparities on the quality of cancer care. Elizabeth Mansfield, Ph.D., is the director of the personalized medicine staff in the Office of In Vitro Diagnostic and Radiological Health (OIR)
|
From page 88... ...
She has also been statistical coauthor on many biomedical papers covering such topics as genomic studies in breast, colon, and lung cancer; colorectal epithelial cell proliferation; serum markers in prostate cancer; molecular characterization of ovarian tumors; Parkinson's disease; motor control disorders; stroke;
|
From page 89... ...
, and founder/director of the UCSF Center for Translational and Policy Research on Personalized Medicine. She has appointments in the UCSF Department of Clinical Pharmacy, the UCSF Institute for Health Policy Studies, and the UCSF Comprehensive Cancer Center.
|
From page 90... ...
Piper has given presentations on evidence-based evaluation of genetic tests at meetings organized by the IOM, AHRQ, and the NCI. Prior experience includes more than 13 years of managing a variety of clinical diagnostic laboratory departments in both academic hospital and commercial clinical laboratory settings, designing and evaluating new laboratory diagnostics for the biomedical industry, consulting with physicians, publishing, and volunteer teaching for professional organizations in laboratory medicine.
|
From page 91... ...
. One of the foremost genitourinary medical oncologists in the country, he also serves as principal investigator of the NIH Specialized Program of Research Excellence in prostate cancer at MSKCC, the Department of Defense Prostate Cancer Research Program (PCRP)
|
From page 92... ...
at the University of Chicago Pritzker School of Medicine in 1975. Following a residency in internal medicine at the University of Texas Southwestern Medical Center and Parkland Memorial Hospital, he received training in medical oncology and clinical pharmacology at the National Cancer Institute from 1977 to 1981.
|
From page 93... ...
Dr. Schilsky is an associate editor of Clinical Cancer Research, Seminars in Oncology, and the Journal of the National Cancer Institute; senior associate editor of Molecular Oncology; and a member of the editorial boards of Cancer Prevention Research, Cancer Investigation, Annals of Surgical Oncology, Journal of Cancer Research and Clinical Oncology, and several other journals.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.